INVO Fertility, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted
INVO Fertility, Inc. (IVF) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted of 2.04 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted · last filed 2026-08-14
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2026-06-30 was 150.00K shares.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2026-03-31 was 1.89M shares, a 10.42% decline year-over-year.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2025-12-31 was -121.21K shares.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2025-09-30 was 150.00K shares.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2025 was 966.29K shares, a 546.43% increase from fiscal 2024.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2024 was 149.48K shares, a 95.90% decline from fiscal 2023.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2023 was 3.64M shares, a 941.01% increase from fiscal 2022.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2022 was 350.00K shares, a 840.30% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 150.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | 2.04M shares 10-Q · filed 2026-08-14 | 1.92M shares derived: sum of 3 quarters · filed 2026-08-14 | 2.07M shares derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | 1.89M shares 10-Q · filed 2026-06-22 | 1.77M shares derived: sum of 2 quarters · filed 2026-06-22 | 1.92M shares derived: sum of 3 quarters · filed 2026-06-22 | 746.03K shares derived: sum of 4 quarters · filed 2026-06-22 |
| 2025-12-31 | -121.21K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-02 | 28.79K shares derived: sum of 2 quarters · filed 2026-06-02 | -1.15M shares derived: sum of 3 quarters · filed 2026-06-02 | 966.29K shares 10-K · filed 2026-06-02 |
| 2025-09-30 | 150.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | -1.03M shares derived: sum of 2 quarters · filed 2025-11-17 | 1.09M shares 10-Q · filed 2025-11-17 | -207.82K shares derived: sum of 4 quarters · filed 2025-11-17 |
| 2025-06-30 | -1.18M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 937.51K shares 10-Q · filed 2025-08-14 | -357.82K shares derived: sum of 3 quarters · filed 2025-08-14 | -357.82K shares derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | 2.11M shares 10-Q · filed 2025-05-20 | 818.43K shares derived: sum of 2 quarters · filed 2025-05-20 | 818.43K shares derived: sum of 3 quarters · filed 2025-05-20 | 1.26M shares derived: sum of 4 quarters · filed 2025-05-20 |
| 2024-12-31 | -1.30M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-30 | -1.30M shares derived: sum of 2 quarters · filed 2025-04-30 | -850.52K shares derived: sum of 3 quarters · filed 2025-04-30 | 149.48K shares 10-K · filed 2025-04-30 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-11-19 | 444.81K shares derived: sum of 2 quarters · filed 2024-11-19 | 1.44M shares 10-Q · filed 2024-11-19 | 1.44M shares derived: sum of 4 quarters · filed 2024-11-19 |
| 2024-06-30 | 444.81K shares derived: 10-Q/A 6 month − 10-Q 3 month · filed 2024-11-19 | 1.44M shares 10-Q/A · filed 2024-11-19 | 1.44M shares derived: sum of 3 quarters · filed 2024-11-19 | 4.66M shares derived: sum of 4 quarters · filed 2024-11-19 |
| 2024-03-31 | 1.00M shares 10-Q · filed 2024-05-15 | 1.00M shares derived: sum of 2 quarters · filed 2024-11-19 | 4.21M shares derived: sum of 3 quarters · filed 2024-11-19 | -3.81M shares derived: sum of 4 quarters · filed 2024-11-19 |
| 2023-12-31 | 0.00 shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-19 | 3.21M shares derived: sum of 2 quarters · filed 2024-11-19 | -4.81M shares derived: sum of 3 quarters · filed 2024-11-19 | 3.64M shares 10-K/A · filed 2024-11-19 |
| 2023-09-30 | 3.21M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -4.81M shares derived: sum of 2 quarters · filed 2023-11-13 | 3.64M shares 10-Q · filed 2023-11-13 | |
| 2023-06-30 | -8.02M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 432.62K shares 10-Q · filed 2023-08-14 | ||
| 2023-03-31 | 8.46M shares 10-Q · filed 2023-05-15 | |||
| 2022-12-31 | 350.00K shares 10-K · filed 2023-04-17 | |||
| 2021-12-31 | 37.22K shares 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |